Acon Laboratories, founded by Jixun Lin, makes the Flowflex at-home COVID-19 tests that took off during the pandemic after receiving U.S. FDA authorization for emergency use in 2021 and clearance for ...
The availability of a four-in-one respiratory virus diagnostic for home use may be a boon to consumers, but some clinicians say it should not be used as a substitute for a physician’s guidance.
CLEVELAND, Ohio — Families can now test for flu, COVID-19 and respiratory syncytial virus with one at-home test. The Flowflex® Plus RSV + Flu A/B + COVID 4-in-1 test is now available in Northeast Ohio ...
ACON Laboratories, Inc. announced the retail availability of the first FDA-cleared home test which allows families to identify four major respiratory infections, including respiratory syncytial virus ...
FDA-cleared test enables at-home detection of RSV, Flu A/B and COVID in adults and pediatric populations. SAN DIEGO, Jan. 23, 2026 /PRNewswire/ -- ACON Laboratories, Inc. today announced the retail ...
For parents and caregivers, the ability to distinguish between RSV, Flu, and COVID can be critical to determine what treatment path to follow. The Flowflex Plus 4-in-1 test is the first respiratory ...
FDA clears first at-home test to detect RSV, influenza, and COVID-19 in infants as young as 6 months
FDA-cleared Flowflex Plus 4-in-1 home test detects RSV, influenza A/B, and COVID-19 in adults and children as young as 6 months. ACON Laboratories, Inc, announced the retail availability of the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results